Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in:

29-10-2024 | Geriatric Oncology | Urology – Review

Comprehensive assessment in uro-oncologic geriatric patients: interdisciplinary management to improve survival

Authors: José Mauricio Ocampo Chaparro, Daniel Andrés Nieva-Posso, Herney Andrés García-Perdomo

Published in: International Urology and Nephrology | Issue 3/2025

Login to get access

Abstract

Urological cancers represent 13.1% of cancer cases in the world, with a mean age of diagnosis of 67 years, making it a geriatric disease. The lack of participation and evaluation of treatments by the geriatric oncologic population has made their mortality rate higher than that of other oncologic population groups, urologic cancers being no exception. The comprehensive management of older people with urological cancers is a bet that is presented to improve the quality of life and survival of this group. Managing elements such as nutritional, physical, cognitive, psychosocial, and sexual status improves the chances of adherence and treatment, contributing significantly to improving the quality of life. The integrated management of the geriatric oncology population has brought positive effects on quality of life, enhancing levels of depression and anxiety and also allowing the classification of oncology patients based on other criteria in addition to their chronologic age, contributing to the management of specialized treatments that have allowed the implementation of more specific interventions with better results.
Literature
1.
2.
3.
Arsoniadis EG, Finlayson E, Potenti F (2020) Is there a role for specialized geriatric centers in treating geriatric cancer patients? Eur J Surg Oncol 46(3):383–386PubMedCrossRef
4.
Pilleron S, Soto-Perez-de-Celis E, Vignat J, Ferlay J, Soerjomataram I, Bray F et al (2021) Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer 148(3):601–608PubMedCrossRef
5.
Outlaw D, Abdallah M, Gil-Jr LA, Giri S, Hsu T, Krok-Schoen JL et al (2022) The evolution of geriatric oncology and geriatric assessment over the past decade. Semin Radiat Oncol 32(2):98–108PubMedPubMedCentralCrossRef
6.
Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD et al (2021) Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin 71(1):78–92PubMedCrossRef
7.
Boyle HJ, Alibhai S, Decoster L, Efstathiou E, Fizazi K, Mottet N et al (2019) Updated recommendations of the International society of geriatric oncology on prostate cancer management in older patients. Eur J Cancer 116:116–136PubMedCrossRef
8.
Fusco D, Ferrini A, Pasqualetti G, Giannotti C, Cesari M, Laudisio A et al (2021) Comprehensive geriatric assessment in older adults with cancer: recommendations by the Italian society of geriatrics and gerontology (SIGG). Eur J Clin Invest 51(1):13347CrossRef
9.
Sourdet S, Brechemier D, Steinmeyer Z, Gerard S, Balardy L (2020) Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology. BMC Cancer 20(1):384PubMedPubMedCentralCrossRef
10.
Porcacchia AS, Pires GN, Ortiz V, Andersen ML, Tufik S (2022) Prostate cancer mortality and costs of prostate surgical procedures in the Brazilian public health system. Int Braz J Urol 48(3):583–590PubMedPubMedCentralCrossRef
11.
12.
Elmehrath AO, Afifi AM, Al-Husseini MJ, Saad AM, Wilson N, Shohdy KS et al (2021) Causes of death among patients with metastatic prostate cancer in the US From 2000 to 2016. JAMA Netw Open 4(8):e2119568PubMedPubMedCentralCrossRef
13.
14.
15.
16.
17.
Jonasch E, Walker CL, Rathmell WK (2021) Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol 17(4):245–261PubMedCrossRef
18.
Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P (2018) Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol 29(2):377–385PubMedCrossRef
19.
Hakenberg OW, Dräger DL, Erbersdobler A, Naumann CM, Jünemann KP, Protzel C (2018) The diagnosis and treatment of penile cancer. Dtsch Arztebl Int 115:646PubMed
20.
Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of bladder cancer. Med Sci 8(1):15
21.
Droz JP, Boyle H, Albrand G, Mottet N, Puts M (2017) Role of geriatric oncologists in optimizing care of urological oncology patients. Eur Urol Focus 3(4–5):385–394PubMedCrossRef
22.
Abizanda Soler P, Rodriguez Mañas L, Molina Garrido MJ (2020) Peculiaridades en la atención y el manejo del anciano oncologico. Tratado de medicina Geriatrica: fundamentos en la atención sanitaria de personas mayores, 2nd edn. Elsevier, pp 1205–1211
23.
Swagerty D (2017) Integrating quality palliative and end-of-life care into the geriatric assessment. Clin Geriatr Med 33(3):415–429PubMedCrossRef
24.
Ocampo-Chaparro JM, Reyes-Ortíz CA, Etayo-Ruiz E (2021) Valoración geriátrica integral en cuidados paliativos: revisión bibliográfica. Medicina Paliativa 28(3):185–197
25.
Yajima S, Masuda H (2024) The significance of <scp>G8</scp> and other geriatric assessments in urologic cancer management: a comprehensive review. Int J Urol 31(6):607–615PubMedCrossRef
26.
Anic K, Birkert S, Schmidt MW, Linz VC, Heimes AS, Krajnak S et al (2022) G-8 geriatric screening tool independently predicts progression-free survival in older ovarian cancer patients irrespective of maximal surgical effort: results of a retrospective cohort study. Gerontology 68(10):1101–1110PubMedCrossRef
27.
28.
Wu Q, Ye F (2023) Prognostic impact of geriatric nutritional risk index on patients with urological cancers: a meta-analysis. Front Oncol 11:12
29.
Bullock AF, Greenley SL, McKenzie GAG, Paton LW, Johnson MJ (2020) Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis, and meta-analysis. Eur J Clin Nutr 74(11):1519–1535PubMedPubMedCentralCrossRef
30.
Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S et al (1999) The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15(2):116–122PubMedCrossRef
31.
Edemekong PF, Bomgaars DL, Sukumaran S, Schoo C (2024) Activities of daily living. J Geriatrics Gerontol 22:115–123
32.
Lauretani F, Ticinesi A, Gionti L, Prati B, Nouvenne A, Tana C et al (2019) Short-physical performance battery (SPPB) score is associated with falls in older outpatients. Aging Clin Exp Res 31(10):1435–1442PubMedCrossRef
33.
Mosquera Angulo H, Nieva-Posso DA, García-Perdomo HA (2024) Sexuality in penile cancer survivors: a rarely discussed problem in uro-oncology. Int J Urol Nursing 18(1):12390CrossRef
34.
Greimel E, Nagele E, Lanceley A, Oberguggenberger AS, Nordin A, Kuljanic K et al (2021) Psychometric validation of the European organisation for research and treatment of cancer-quality of life questionnaire sexual health (EORTC QLQ-SH22). Eur J Cancer 154:235–245PubMedCrossRef
35.
Barros R, Favorito LA, Nahar B, Almeida R Jr, Ramasamy R (2023) Changes in male sexuality after urologic cancer: a narrative review. Int Braz J Urol 49(2):175–183PubMedCrossRef
36.
37.
Jia X, Wang Z, Huang F, Su C, Du W, Jiang H et al (2021) A comparison of the mini-mental state examination (MMSE) with the Montreal cognitive assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC Psychiatry 21(1):485PubMedPubMedCentralCrossRef
38.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699PubMedCrossRef
39.
Adrián-Arrieta L, Casas-Fernández de Tejerina JM (2018) Autopercepción de enfermedad en pacientes con enfermedades crónicas. Medicina de Familia SEMERGEN 44(5):335–341PubMedCrossRef
40.
Henry BJ (2022) Symptom management in oncology: depression and anxiety. Semin Oncol Nurs 38(1):151251PubMedCrossRef
41.
Dinesh AA, Helena Pagani SPS, Brunckhorst O, Dasgupta P, Ahmed K (2021) Anxiety, depression and urological cancer outcomes: a systematic review. Urol Oncol: Seminars Origin Investig 39(12):816–828CrossRef
42.
43.
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17(1):37–49PubMedCrossRef
44.
Cheng JJ, Azizoddin AM, Maranzano MJ, Sargsyan N, Shen J (2022) Polypharmacy in oncology. Clin Geriatr Med 38(4):705–714PubMedCrossRef
45.
Parmelee PA, Thuras PD, Katz IR, Lawton MP (1995) Validation of the cumulative illness rating scale in a geriatric residential population. J Am Geriatr Soc 43(2):130–137PubMedCrossRef
46.
Gökbuget N, Ihrig K, Stadler M, Stelljes M, Elmaagacli A, Starck M et al (2023) General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia. Haematologica 108(7):1758–1767PubMedPubMedCentralCrossRef
47.
Thompson MQ, Theou O, Tucker GR, Adams RJ, Visvanathan R (2020) FRAIL scale: predictive validity and diagnostic test accuracy. Australas J Ageing 39(4):529–536CrossRef
48.
Delgado-Silveira E, Molina Mendoza MD, Montero-Errasquín B, Muñoz García M, Rodríguez Espeso EA, Vélez-Díaz-Pallarés M et al (2023) Versión en español de los criterios STOPP/START 3. Avances en la detección de la prescripción inapropiada de medicamentos en personas mayores. Rev Esp Geriatr Gerontol 58(5):101407PubMedCrossRef
49.
Canatan D, Yılmaz O, Sonmez Y, Cim A, Baykara M, Savas M et al (2022) Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer. Acta Biomed 93(3):e2022089PubMedPubMedCentral
50.
Hickey A, Barker M, McGee H, O’Boyle C (2005) Measuring health-related quality of life in older patient populations. Pharmacoeconomics 23(10):971–993PubMedCrossRef
51.
Johnson C, Fitzsimmons D, Gilbert J, Arrarras JI, Hammerlid E, Bredart A et al (2010) Development of the European organisation for research and treatment of cancer quality of life questionnaire module for older people with cancer: the EORTC QLQ-ELD15. Eur J Cancer 46(12):2242–2252PubMedCrossRef
52.
Wolfson JA, Sun CL, Wyatt LP, Hurria A, Bhatia S (2015) Impact of care at comprehensive cancer centers on outcome: results from a population-based study, cancer, vol 121. Wiley, pp 3885–3893
53.
Belda-Ferre M, Garcia-Segui A, Pacheco-Bru JJ, Valencia-Guadalajara VJ, Verdú-Verdú LP, Sánchez-Cano E et al (2022) Multicenter study on multidisciplinary committees in advanced prostate cancer. Actas Urológicas Españolas (English Edition) 46(2):106–113CrossRef
54.
Wirth M, Fossati N, Albers P, Bangma C, Brausi M, Comperat E et al (2019) The European prostate cancer centres of excellence: a novel proposal from the european association of urology prostate cancer centre consensus meeting. Eur Urol 76(2):179–186PubMedCrossRef
55.
Askelin B, Hind A, Paterson C (2021) Exploring the impact of uro-oncology multidisciplinary team meetings on patient outcomes: a systematic review. Eur J Oncol Nurs 54:102032PubMedCrossRef
Metadata
Title
Comprehensive assessment in uro-oncologic geriatric patients: interdisciplinary management to improve survival
Authors
José Mauricio Ocampo Chaparro
Daniel Andrés Nieva-Posso
Herney Andrés García-Perdomo
Publication date
29-10-2024
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2025
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-024-04254-8

Other articles of this Issue 3/2025

Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients

“Enhancing prognosis in renal AL amyloidosis: insights from recent biomarker and staging model research”

Mesenchymal stem cell-derived exosomes in renal ischemia–reperfusion injury: a new therapeutic strategy

  • Nephrology – Review

Does the hemodialysis program affect the prostate-specific antigen (PSA) serum levels in patients with end-stage renal disease (ESRD)? A cross-sectional descriptive study

Associations between frailty status and humoral response to SARS-cov-2 vaccination in kidney transplantation and dialysis

Association between blood lead levels and serum creatinine: a cross-sectional study

  • Diabetes
  • Nephrology – Original Paper

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar
Image Credits